Compounding Pharmacies Say Removing Tirzepatide From Shortage List Was An Error
FORT WORTH, Texas — The U.S. Food and Drug Administration violated federal law when it “abruptly declared the shortage” of tirzepatide, an FDA-approved drug for diabetes and weight loss, over and...To view the full article, register now.
Already a subscriber? Click here to view full article